182 Results

People

  1. Motzer
    Motzer
  2. Aghajanian
    Aghajanian
  3. Lis
    Lis
  4. Scher
    Scher
  5. Vickers
    Vickers
  6. Bilsky
    Bilsky
  7. Zelenetz
    Zelenetz
  8. Antunes
    Antunes
  9. De Angelis
    De Angelis
  10. Gulati
    Gulati

Groups

  1. Department of Medicine (105)
  2. Solid Tumor Oncology Division (72)
  3. Hematologic Malignancies, Division of (34)
  4. Genitourinary Oncology Service (28)
  5. Center for Hematologic Malignancies (27)
  6. Radiology, Department of (20)
  7. Epidemiology and Biostatistics (14)
  8. Gastrointestinal Oncology Service (14)
  9. Population Sciences Research Program (14)
  10. Surgery (14)
  1. "backache"
Formats
  1. Journal Article (173)
  2. Review (5)
  3. Guidelines (2)
  4. Correspondence (1)
  5. Research Letter (1)
Groups
  1. Department of Medicine (105)
  2. Solid Tumor Oncology Division (72)
  3. Hematologic Malignancies, Division of (34)
  4. Genitourinary Oncology Service (28)
  5. Center for Hematologic Malignancies (27)
  6. Radiology, Department of (20)

More Groups

People
  1. Robert Motzer (11)
  2. Andrew Vickers (6)
  3. Carol Aghajanian (6)
  4. Eric Lis (6)
  5. Howard Scher (6)
  6. Amitabh Gulati (5)

More People

Years
  1. 2025 (6)
  2. 2024 (12)
  3. 2023 (11)
  4. 2022 (7)
  5. 2021 (6)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (14)
  2. Lancet Oncology (13)
  3. Clinical Cancer Research (11)
  4. Cancer (6)
  5. Annals of Oncology (5)
  6. Blood (5)

More Publications

Publishers
  1. Elsevier Inc. (29)
  2. Elsevier Science, Inc. (20)
  3. American Society of Clinical Oncology (14)
  4. Nature Publishing Group (13)
  5. Wiley Blackwell (13)
  6. American Association for Cancer Research (11)

More Publishers

Results (182)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Influence of control group on effect size in trials of acupuncture for chronic pain: A secondary analysis of an individual patient data meta-analysis
    Journal Article

    MacPherson, H.; Vertosick, E.; Lewith, G.; Linde, K.; Sherman, K. J.; Witt, C. M.; Vickers, A. J.
    PLoS ONE (2014)

    Fulltext@MSK | Save
  • Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: An open-label, randomised phase 3 trial
    Journal Article

    Motzer, R. J.; Porta, C.; Vogelzang, N. J.; Sternberg, C. N.; Szczylik, C.; Zolnierek, J.; Kollmannsberger, C.; Rha, S. Y.; Bjarnason, G. A.; Melichar, B.; more...
    Lancet Oncology (2014)

    Fulltext@MSK | Save
  • A woman with metastatic pancreatic neuroendocrine tumor
    Journal Article

    Shoushtari, A. N.; Covey, A. M.; Zaatari, G.; Shamseddine, A.; Epstein, A. S.; Haydar, A.; Naghy, M.; Mukherji, D.; Kelsen, D. P.; Abou-Alfa, G. K.; more...
    Gastrointestinal Cancer Research (2014)

    Fulltext@MSK | Save
  • Safety and efficacy of everolimus with exemestane vs. exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2
    Journal Article

    Pritchard, K. I.; Burris, H. A. 3rd; Ito, Y.; Rugo, H. S.; Dakhil, S.; Hortobagyi, G. N.; Campone, M.; Csöszi, T.; Baselga, J.; Puttawibul, P.; more...
    Clinical Breast Cancer (2013)

    Fulltext@MSK | Save
  • A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer
    Journal Article

    Tolaney Dr, S. M.; Najita, J.; Sperinde, J.; Huang, W.; Chen, W. Y.; Savoie, J.; Fornier, M.; Winer, E. P.; Bunnell, C.; Krop, I. E.
    Annals of Oncology (2013)

    Fulltext@MSK | Save
  • A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer
    Journal Article

    Rathkopf, D. E.; Picus, J.; Hussain, A.; Ellard, S.; Chi, K. N.; Nydam, T.; Allen-Freda, E.; Mishra, K. K.; Porro, M. G.; Scher, H. I.; more...
    Cancer Chemotherapy and Pharmacology (2013)

    Fulltext@MSK | Save
  • Benign notochordal cell tumors of the spine: Natural history of 8 patients with histologically confirmed lesions
    Journal Article

    Iorgulescu, J. B.; Laufer, I.; Hameed, M.; Boland, P.; Yamada, Y.; Lis, E.; Bilsky, M.
    Neurosurgery (2013)

    Fulltext@MSK | Save
  • A phase I trial of the kinesin spindle protein (Eg5) inhibitor AZD4877 in patients with solid and lymphoid malignancies
    Journal Article

    Gerecitano, J. F.; Stephenson, J. J.; Lewis, N. L.; Osmukhina, A.; Li, J.; Wu, K.; You, Z.; Huszar, D.; Skolnik, J. M.; Schwartz, G. K.
    Investigational New Drugs (2013)

    Fulltext@MSK | Save
  • Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumab
    Journal Article

    Schwartzberg, L. S.; Tauer, K. W.; Hermann, R. C.; Makari-Judson, G.; Isaacs, C.; Beck, J. T.; Kaklamani, V.; Stepanski, E. J.; Rugo, H. S.; Wang, W.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • A phase II study of trastuzumab emtansine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who were previously treated with trastuzumab, lapatinib, an anthracycline, a taxane, and capecitabine
    Journal Article

    Krop, I. E.; LoRusso, P.; Miller, K. D.; Modi, S.; Yardley, D.; Rodriguez, G.; Guardino, E.; Lu, M.; Zheng, M.; Girish, S.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save